Learn the essential compliance steps to confidently offer biologics in Texas. This guide covers state and FDA regulations, patient consent, and best practices to help you establish compliant stem cell therapy services.
This guide provides Texas clinics with a clear pathway to compliance for offering biologic treatments, such as stem cell therapy. Covering federal and state regulations, informed consent, and operational standards, this resource empowers providers to confidently meet Texas's compliance requirements.
The U.S. Food and Drug Administration (FDA) governs human cells, tissues, and cellular and tissue-based products (HCT/Ps) under regulations that ensure the safety and efficacy of biologics.
FDA Guidance on HCT/P
For comprehensive guidelines on the FDA’s HCT/P regulations, see the FDA’s FDA HCT/P Regulations page. In addition to basic product safety and efficacy, clinics offering biologic therapies must ensure that their protocols align with 21 CFR Part 1271, covering donor eligibility, cell handling, and other key compliance measures.
Texas has specific guidelines for biologics. Compliance with these guidelines enables clinics to operate legally while focusing on patient safety and procedural integrity. For Texas regulations and licensing details, consult the Texas Department of State Health Services: Texas DSHS.
In Texas, only licensed physicians(MDs/DOs) may administer stem cell therapies. Clinics must verify that providers meet Texas’s licensing standards for performing biologic injections. For more information, visit the Texas Medical Board’s website: Texas Medical Board.
Patient Informed Consent
Informed consent is critical for patient awareness of risks, benefits, and the experimental nature of certain biologic therapies. Texas law requires clinics to disclose:
Procedure risks and benefits
Alternative treatment options
Potential side effects and outcomes
Documentation of informed consent should be obtained before treatment. For consent form guidance, see the FDA’s resources on patient communication: FDA Patient Engagement.
Establish clear protocols for pre- and post-treatment to enhance patient safety and treatment efficacy. Protocols should include screening, monitoring, and follow-up care procedures aligned with FDA and Texas standards.
Develop SOPs covering patient eligibility, biologic handling, and treatment administration. These procedures ensure consistent compliance and can serve as reference materials during audits or inspections.
Texas clinics must carry appropriate medical liability insurance to cover biologic therapy services. Ensure that your insurance policy includes specific coverage for experimental treatments like stem cell therapy.
All marketing materials for biologic treatments must comply with FDA and Texas advertising standards. Avoid exaggerated claims and clearly state when treatments are experimental. The FDA Advertising Guidelines provide additional guidance.
This guide is provided as an informational resource to help clinics and practitioners understand general compliance requirements for biologics in Texas. It is not intended to serve as legal advice or replace consultation with qualified legal professionals. Regulations may vary and are subject to change; clinics and practitioners should consult legal counsel or regulatory experts for advice specific to their circumstances and ensure full compliance with all applicable federal and state laws. The authors and publishers of this guide disclaim any liability arising from its use or reliance on the information provided.
The purpose of this website is to provide information for on protocols and general information about biologics, including the regulations and basic information.
The purpose of this website is to provide information for on protocols and general information about biologics, including the regulations and basic information.
About
Our mission is to equip practitioners with essential knowledge on biologics, covering protocols, regulatory guidelines, and foundational insights. This site serves as a trusted resource for navigating the evolving landscape of stem cell applications in clinical practice.
Disclaimer
The information on this website is provided solely for informational purposes and has not been reviewed or approved by the FDA or any other regulatory authority. It does not constitute medical advice, diagnosis, treatment, or any guarantees of medical outcomes and should not be used as a substitute for formal medical education and training, nor as a substitute for consultation with qualified healthcare professionals. Similarly, the content does not provide legal advice or guidance on regulatory compliance and should not replace consultations with qualified legal professionals.
DiscoverBiologics.com makes no representations or warranties, express or implied, regarding the accuracy, reliability, or applicability of the information provided to individual health circumstances or the legal use and adoption of biological products by clinics or providers.
By accessing this website, you agree to the terms and conditions outlined herein and accept full responsibility for compliance and clinical decisions made within your practice. You also acknowledge that you have been encouraged to review the disclaimer page and understand that any reliance on the information provided is voluntary and at your own risk and sole discretion.
2025 © All Rights Reserved. DiscoverBiologics.com